ESCO (NYSE:ESE) Misses Q2 CY2026 Revenue Estimates
ESCO (NYSE:ESE) reported Q2 CY2026 revenue of $339 million, up 14.4% year on year, but below analysts’ estimates. Full-year revenue guidance was $1.32 billion at the midpoint, near consensus. Non-GAAP adjusted EPS was $2.20, 3.9% above consensus. The stock fell 1.1% to $324.21 after the report.
How this was made

The 30-second read
Why it matters
Traders can reassess near-term demand and margin durability using the revenue miss, EPS beat, and guidance positioning versus consensus.
Market read
Q2 shows revenue underperformance versus estimates but profitable EPS outperformance, with full-year revenue near consensus and EPS guidance ahead, creating a mixed setup for the stock.
What to watch
The article notes EBITDA fell slightly short and cites analyst expectations for revenue growth decelerating to 7.2%, which could matter more than the EPS beat for valuation.
Background
ESCO is an engineered products manufacturer serving aerospace, defense, and utility markets, and the article frames its Q2 performance versus Wall Street expectations.
Ticker impact
ESCO reported Q2 CY2026 revenue of $339M, up 14.4% YoY but below Wall Street estimates, while adjusted EPS was $2.20 and beat consensus.
Near-term volatility likely, with downside risk if investors focus on the revenue miss and demand deceleration.
The article provides concrete Q2 results (revenue miss, EPS beat) plus full-year revenue and EPS guidance versus consensus, which typically drives immediate repricing and sets a near-term narrative for demand.
Market effects
Defense and aerospace component suppliers may see read-through on near-term demand expectations if revenue misses persist.
No specific regional spillover beyond US industrials sentiment.
Limited global relevance; impacts are primarily within US industrials/defense supply chain expectations.
Counterpoint
The revenue miss may be temporary given full-year revenue guidance is near consensus and operating margin stability suggests costs are controlled.
Key entities
- companyESCO
NYSE-listed engineered products manufacturer reporting Q2 CY2026 results and full-year guidance.
- market_referenceWall Street estimates
Consensus benchmarks for Q2 revenue, adjusted EPS, and full-year guidance cited in the article.
